FDA Panel Won't Back Sanofi Blood Thinner For Cancer Patients
A U.S. Food and Drug Administration advisory panel voted overwhelmingly Wednesday not to recommend approval of a Sanofi Aventis US LLC anticoagulant for cancer patients receiving chemotherapy, saying the company's main...To view the full article, register now.
Already a subscriber? Click here to view full article